On October 10, 2021, dozens of large engineering vehicles wearing red flowers lined up neatly in the plot of No. 30, Keji Road, Phase III, Miyun District, Beijing. The Public Health Emergency Industry and Critical Illness Diagnosis and Treatment Technology Engineering Center (hereinafter referred to as the "Engineering Center") invested by Fosun Beiling (Beijing) Medical Technology Co., LTD. (hereinafter referred to as "Fosun Beiling") officially laid the foundation stone and started construction.

Zhang Tianjie, Deputy Director of the Standing Committee of the People's Congress of Miyun District, Beijing; Li Yousheng, Deputy Secretary of the Working Committee of Miyun Park, Zhongguancun Science and Technology Park; Guan Xiaohui, Executive President and Chief Financial Officer of Fosun Pharma; Zhu Wenkui, Senior Assistant to Fosun President and Chief Executive Officer of Fosun Trading Company; Wen Deyong, Liu Yi, Yang Jianpeng and other management leaders of Fosun Pharma; Peng Lijun, general manager of Special Vehicle Division of Jiangxi Jiangling Automobile Group, attended the ceremony. More than 80 guests from Beijing Automobile Industry Association, China Federation of Logistics and Purchasing, China Medical Equipment Association Emergency Treatment Equipment Branch, cooperation units, engineering and construction units, experts, media and other representatives jointly witnessed this historic moment.

Liu Yi, Vice President of Fosun Pharmaceutical and Chairman of Fosun Beiling, delivered a speech

Liu Yi, vice president of Fosun Pharmaceutical and chairman of Fosun Beiling, delivered a welcome speech, saying that the grand foundation laying ceremony of Fosun Beiling Engineering Center was held here, marking a key step in the construction of the project and entering a new stage. In the future, Fosun Beiling will promote project construction with high standards and strict requirements to ensure timely completion and early results; Continue to focus on pre-hospital emergency care, public health and critical illness diagnosis and treatment and other fields, continue to enrich product types, accelerate the improvement of business layout, strive to develop into an industry leader Fosun Miyun layout, to promote the development of medicine and health industry, improve people's health and well-being, and actively contribute!

Peng Lijun, general manager of Special Vehicle Division of Jiangxi Jiangling Automobile Group, delivered a speech

Peng Lijun, general manager of Special Vehicle Division of Jiangxi Jiangling Automobile Group, congratulated Fosun Beiling Engineering Center on the commencement of construction. He said that Fosun Pharmaceutical and Jiangling Motor are leaders in their respective segments, and the long-term strategic cooperation between Jiangling Motor and Fosun Beiling in medical ambulance vehicles is even stronger. It is hoped that Jiangling Motor and Fosun Pharmaceutical will take this groundbreaking ceremony as an opportunity to carry out deeper cooperation in a broader space in the future and march to a new height together!

Zhang Tianjie, Deputy Director of the Standing Committee of the People's Congress of Miyun District, Beijing, delivered a speech

Zhang Tianjie, deputy director of the Standing Committee of the People's Congress of Miyun District, Beijing, on behalf of the Miyun District Party Committee, the district government, the district People's Congress and the district Political Consultative Conference, congratulated on the smooth foundation of the Fosun Beiling Engineering Center project, and fully affirmed the innovation ability of Fosun Pharmaceutical Group to deeply cultivate the health industry and the strategic positioning of Fosun Beiling project. Miyun District Party Committee and district Government will continue to strengthen the service guarantee of Miyun Economic Development Zone, escort the smooth construction of the project, and ensure that the project is completed, put into operation and achieved early!

Mr. Guan Xiaohui, Executive President and Chief Financial Officer of Fosun Pharmaceutical, delivered a speech

Guan Xiaohui, executive president and chief financial officer of Fosun Pharmaceutical, said in his speech that the promotion of the construction of the engineering center with Fosun Beiling as the main body is an important layout for Fosun Pharmaceutical Group to focus on the "post-epidemic" era and strengthen the capacity building of products and services in the field of public health emergency and critical illness. It is also a key measure for Fosun Beiling to deepen its development and enhance its core competitiveness. The foundation laying ceremony marked that Fosun Pharmaceutical Group and Miyun District have entered a new stage of cooperation with close cooperation and joint progress around the development of the pharmaceutical and health industry. It is hoped that Fosun Beiling can promote the implementation of the project with high quality, strive to become an international advanced technology "intelligent manufacturing" base, and strive to make positive contributions to the development of the pharmaceutical and health industry.

Fosun Beiling signed a strategic cooperation agreement with Cheng Research Institute

Fosun Beiling and Vivis Medical signed a strategic cooperation agreement

At the groundbreaking ceremony on the same day, Fosun Beiling signed strategic cooperation agreements with China Mobile (Chengdu) Industrial Research Institute (hereinafter referred to as "Cheng Research Institute") and Suzhou Weiwei Medical Technology Co., LTD. (hereinafter referred to as "Weiwei Medical").

Fosun Beiling Engineering Center project ribbon cutting ceremony

Fosun Beiling Engineering Center project foundation

Group photo of the groundbreaking ceremony

Salute, ribbon lift-off, participating in the foundation laying ceremony for the Fosun Beiling Engineering Center project leaders cut the ribbon, foundation and soil, pile deep new industry, the foundation of the grand exhibition! Fosun Beiling Engineering Center project foundation laying ceremony successfully completed!

Public Health Emergency Industry and Critical Illness Diagnosis and Treatment technology Engineering center

Fosun Beiling Public Health Emergency Industry and Critical Illness Diagnosis and Treatment Technology Engineering Center is located in Beijing Miyun Economic Development Zone, one of the high-tech industrial clusters in China, with significant location advantages. The total construction area of the project is more than 56,000 square meters, which will be planned and constructed around the four functional sectors of "production, research, innovation and protection", build a high-end intelligent industrial cloud manufacturing platform, and create an "intelligent manufacturing" base that integrates research and development, production, marketing and service, and has international advanced technology. The center is composed of production buildings, joint factories, ingredients warehouse, non-motorized sheds, dormitories and other buildings, and is expected to be completed by the end of 2022 and officially put into operation in January 2023.

As a core member of Fosun Medical device sector, Fosun Beiling, under the leadership of Fosun Pharmaceutical Group, has seized policy opportunities and prioritised layout in the fields of public health, emergency rescue and critical illness diagnosis and treatment. The Public health Emergency Industry and Critical illness Diagnosis and treatment Technology Engineering Center is the first key project in Fosun Beiling's future strategic planning, and also marks a solid step in the company's major strategic upgrading of industrial structure, which is of great significance to promote the development of the company's special vehicles and medical devices into a scale and level.

2021 is the first year of the 14th Five-Year Plan, and China's health industry will enter a new historical stage. In this period, public health capacity building will become the focus of development, Fosun Beiling, as a pioneer in the field of pre-hospital emergency care in China, will always adhere to the feelings of industry to serve the country, seize the "14th Five-Year Plan" development opportunities, continue to implement the concept of innovative development, through the construction of a new development pattern, expand the new ecology of people's life and health development, and promote the company's scale and high-quality business development!

Fosun Beiling (Beijing) Medical Technology Co., LTD

Fosun Beiling (Beijing) Medical Technology Co., Ltd. is a core member of Fosun Medical Device sector. Adhere to the "protect life with science and technology", rely on digital technology, take mobile medical platform as the carrier, integrate all on-board medical equipment, build a leading smart mobile medical digital platform, provide customers with professional special vehicles and medical equipment digital integration services, committed to becoming a domestic leader in the field of pre-hospital emergency care and critical illness. To support the development of China's public health, emergency rescue and critical illness diagnosis and treatment industries.

China Mobile (Chengdu) Industrial Research Institute

China Mobile (Chengdu) Industrial Research Institute is a wholly-owned subsidiary of China Mobile Communications Group Co., LTD. Relying on China Mobile's strong network scale, connection scale and user scale advantages, forging a new generation of information and communication products led by 5G, focusing on building a "government, industry, university and research" platform in the field of information and communication in various industries, and creating an agile, efficient, open and shared digital production capacity. It is committed to becoming an innovator in the professional field, an integrator of industrial resources, and an enabler of industrial intelligence development.

Suzhou Weiwei Medical Technology Co., LTD

Suzhou VIVEST MEDICAL is an innovative medical technology enterprise focusing on prevention and treatment of ventricular arrhythmias and cardiac rhythm data services. Vivis Medical is committed to providing the world's leading solution for the whole process of prevention, monitoring, treatment and rehabilitation of malignant arrhythmias, creating a non-invasive ventricular arrhythmia and sudden cardiac death prevention platform, and has developed two products with complete independent intellectual property rights - wearable automatic external defibrillator (WCD) and automatic external defibrillator (AED).